References

1. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, Lee R, Small PL. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283 (5403):854-857, 1999. [ PubMed ]
2. Hayman J. Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol. 1993;46:5-9. [PubMed ]
3. Horsburgh CR Jr, Meyers WM. Buruli ulcer. In: Horsburgh CR Jr, Nelson AM, eds. Pathology of Emerging Infections. Washington, DC: American Society for Microbiology; 1997:119-134.
4. Meyers WM. Mycobacterial infections of the skin. In: Doerr W, Seifert G, eds. Tropical Pathology. 2nd ed. Berlin, Germany: Springer-Verlag; 1995:291-377.
5. Portaels F, Aguiar J, Debacker M, Guedenon A, Steunou C, Zinsou C, Meyers WM. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect.Immun. 72 (1):62-65, 2004. [ PubMed ]
6. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet 354 (9183):1013-1018, 1999. [ PubMed ]
7. Asiedu K, Scherpbier R, Raviglione M, eds. Buruli Ulcer: Mycobacterium ulcerans Infection. Geneva, Switzerland: World Health Organization; 2000.
8. Buntine J, Croft K, eds. Management of Mycobacterium ulcerans Disease (Buruli Ulcer). Geneva, Switzerland: World Health Organization; 2001.
9. Portaels F, Johnson P, Meyers WM, eds. Diagnosis of Mycobacterium ulcerans Disease (Buruli Ulcer). Geneva, Switzerland: World Health Organization; 2001.

Links

1. CDC
2. WHO